MDS Nordion Initiates Manufacture Of Cardiac Imaging Agent

MDS Nordion, a provider of medical isotopes and radiopharmaceuticals, has announced that it has commenced the manufacture of CardioGen-82 (Rubidium-82 generators), for Bracco.

MDS Nordion has designed and built a dedicated manufacturing suite within its FDA approved, Good Manufacturing Practices (GMP)-compliant production facility in Ottawa.

Production of CardioGen-82 began on June 9, 2009.

CardioGen-82, the only generator-based, cardiac Positron Emission Tomography (PET) perfusion imaging agent approved by the FDA, produces Rubidium-82, using a specialized generator technology.

Steve West, President, MDS Nordion, said: MDS Nordion provides a full spectrum of services for the development and commercialization of novel radiopharmaceuticals. For more than 10 years, companies like Bracco have been relying on our proven track record for innovative solutions, quality, and reliability that make MDS Nordion the partner of choice.